Skip to main content
SpringerLink
Log in

Blood Lipid Levels and Antihypertensive Therapy

  • Published:
Drugs Aims and scope Submit manuscript

Summary

The effects of elevated blood lipid concentrations on cardiovascular mortality and morbidity are reviewed, with particular emphasis on how high fat diets and antihypertensive drugs can influence the risk of developing atherosclerosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Amery A, Birkenhäger W, Bulpitt C, Clement D, Deruyltere M, et al. Influence of anti-hypertensive therapy on serum cholesterol in elderly hypertensive patients. Acta Cardiologica 37: 235–244, 1982

    PubMed  CAS  Google Scholar 

  • Ames RP. Coronary heart disease and the treatment of hypertension: impact of diuretics on serum lipids and glucose. Journal of Cardiovascular Pharmacology 6: S466–S473, 1984

    Article  PubMed  Google Scholar 

  • Ames RP, Hill P. Elevation of serum lipid levels during diuretic therapy of hypertension. American Journal of Medicine 61: 748–757, 1976

    Article  PubMed  CAS  Google Scholar 

  • Blackburn H. Coronary risk factors. How to evaluate and manage them. European Journal of Cardiology 2-3: 249–283, 1985

    Google Scholar 

  • Burris JF, Freis ED. Thiazides do not cause long-term increases in serum lipid concentrations. Archives of Internal Medicine 145: 2264–2266, 1985

    Article  PubMed  CAS  Google Scholar 

  • Chobanian AV. Effects of beta blockers and other antihypertensive drugs on cardiovascular risk. American Journal of Cardiology 59: 48F–52F, 1987

    Article  PubMed  CAS  Google Scholar 

  • Giuntoli F, Scalabrino A, Galeone F, Birindelli A, Natali A, et al. Antihypertensive and metabolic effects of a long-term treatment with acebutolol. Current Therapeutic Research 36: 188–194, 1984

    Google Scholar 

  • Goldman Al, Steel BW, Schnaper HW, Fritz A, Frohlich ED, et al. Serum lipoprotein levels during chlorthalidone therapy: a Veterans Administration-National Heart, Lung, and Blood Institute cooperative study on antihypertensive therapy: mild hypertension. Journal of the American Medical Association 244: 1691–1695, 1980

    Article  PubMed  CAS  Google Scholar 

  • Grimm RH, Leon AS, Hunninghake DB, Lenz K, Hannan P, et al. Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients: a double-blind controlled trial. Annals of Internal Medicine 94: 7–11, 1981

    PubMed  Google Scholar 

  • Helgeland A, Hjermann I, Holme I, Leren P. Serum triglycerides and serum uric acid in untreated and thiazide-treated patients with mild hypertension. The Oslo study. American Journal of Medicine 64: 34–38, 1978

    Article  PubMed  CAS  Google Scholar 

  • Kannel WB, Gordon T, McGee D. Diuretics and serum cholesterol. Lancet 1: 1362–1363, 1977

    Article  PubMed  CAS  Google Scholar 

  • Lasser NL, Grandits G, Caggiula AW, Cutler JA, Grimm Jr RH, et al. Effects of antihypertensive therapy on plasma lipids and lipoproteins in the Multiple Risk Factor Intervention Trial. American Journal of Medicine 76 (Suppl.): 52–66, 1984

    Article  PubMed  CAS  Google Scholar 

  • Lehtonen A. Effect of beta blockers on blood lipid profile. American Heart Journal 109: 1192–1196, 1985

    Article  PubMed  CAS  Google Scholar 

  • Leren P. Effect of alpha- and beta-blocker therapy on blood lipids: European experience. American Journal of Medicine 76: 67–71, 1985

    Article  Google Scholar 

  • Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. Journal of the American Medical Association 251: 351–374, 1984

    Article  Google Scholar 

  • MacMahon SW, Macdonald GJ, Blacket RB. Plasma lipoprotein levels in treated and untreated hypertensive men and women. The National Heart Foundation of Australia Risk Factor Prevalence Study. Arteriosclerosis 5: 391–396, 1985

    Article  PubMed  CAS  Google Scholar 

  • Middeke M, Weisweiler P, Schwandt P, Holzgreve H. Serum lipoproteins during antihypertensive therapy with beta blockers and diuretics: a controlled long-term comparative trial. Clinical Cardiology 10: 94–98, 1987

    Article  PubMed  CAS  Google Scholar 

  • Nakamura H. Effects of antihypertensive drugs on plasma lipids. American Journal of Cardiology 60: 24E–28E, 1987

    Article  PubMed  CAS  Google Scholar 

  • Pool PE, Seagren SC, Salel AF, Skalland ML. Effects of diltiazem on serum lipids, exercise performance and blood pressure: randomized, double-blind placebo-controlled evaluation for systemic hypertension. American Journal of Cardiology 56: 86H–91H, 1985

    Article  PubMed  CAS  Google Scholar 

  • Rifkind BM. The Lipid Research Clinics Coronary Primary Prevention Trial. Drugs 31(Suppl. 1): 53–60, 1986

    Article  PubMed  Google Scholar 

  • Schiffl H, Weidmann P, Mordasini R, Riesen W, Bachmann C. Reversal of diuretic-induced increases in serum low-density-lipoprotein cholesterol by the beta blocker pindolol. Metabolism 31: 411–415, 1982

    Article  PubMed  CAS  Google Scholar 

  • Schoenfeld MR, Goldberger E. Hypercholesterolemia induced by thiazides: a pilot study. Current Therapeutic Research 6: 180–184, 1964

    PubMed  CAS  Google Scholar 

  • van Brummelen P. The relevance of intrinsic sympathomimetic activity for β-blocker-induced changes in plasma lipids. Journal of Cardiovascular Pharmacology 5: S51–S55, 1983

    Article  PubMed  Google Scholar 

  • Veterans Administration Cooperative Study Group on Antihypertensive Agents. Comparison of propranolol and hydrochlorothiazide for initial treatment of hypertension. I. Results of short-term titration with emphasis on racial differences in response. II. Results of long-term treatment. Journal of the American Medical Association 248: 2004–2011, 1982

    Article  Google Scholar 

  • Wallace RB, Hunninghake DB, Chambless LE, Heiss G, Wahl P, et al. A screening survey of dyslipoproteinemias associated with prescription drug use. The Lipid Research Clinics Program Prevalence Study. Circulation 73(Suppl. I): I–70–I–79, 1986

    Google Scholar 

  • Weidmann P, Gerber A, Mordasini R. Effects of antihypertensive therapy on serum lipoproteins. Hypertension 5: III–120–III–131, 1983

    Article  Google Scholar 

  • Weinberger MH. Antihypertensive therapy and lipids. Evidence, mechanisms and implications. Archives of Internal Medicine 145: 1102–1105, 1985

    Article  PubMed  CAS  Google Scholar 

  • Williams WR, Borhani NO, Schnaper HW, Schneider KA, Slotkoff L, on behalf of the Hypertension Detection and Follow-up Program (HDFP) Cooperative Group. The relationship between diuretics and serum cholesterol in HDFP participants (abstr.). Journal of the American College of Cardiology 1: 623, 1983

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pathology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA

    William C. Roberts

Authors
  1. William C. Roberts
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This paper was originally published in American Journal of Cardiology 60: 33E–35E, 1987. It is reproduced here with permission from the journal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roberts, W.C. Blood Lipid Levels and Antihypertensive Therapy. Drugs 36 (Suppl 2), 6–10 (1988). https://doi.org/10.2165/00003495-198800362-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198800362-00003

Keywords

Search

Navigation